KeyBank National Association
PCRX icon

KeyBank National Association’s Pacira BioSciences PCRX Stock Holding History

KeyBank National Association’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,683
Closed -$388K – 1059
2023
Q2 		$388K Buy
9,683
+1,030
+12% +$42.6K ﹤0.01% 794
2023
Q1 		$353K Sell
8,653
-74
-0.8% -$2.94K ﹤0.01% 836
2022
Q4 		$337K Buy
8,727
+530
+6% +$25.8K ﹤0.01% 838
2022
Q3 		$436K Buy
8,197
+1,924
+31% +$107K ﹤0.01% 706
2022
Q2 		$366K Sell
6,273
-302
-5% -$19.8K ﹤0.01% 804
2022
Q1 		$502K Buy
6,575
+18
+0.3% +$1.2K ﹤0.01% 726
2021
Q4 		$395K Hold
6,557
– – ﹤0.01% 856
2021
Q3 		$367K Hold
6,557
– – ﹤0.01% 886
2021
Q2 		$398K Hold
6,557
– – ﹤0.01% 854
2021
Q1 		$460K Sell
6,557
-3
-0% -$214 ﹤0.01% 815
2020
Q4 		$393K Hold
6,560
– – ﹤0.01% 830
2020
Q3 		$394K Buy
6,560
+27
+0.4% +$1.57K ﹤0.01% 756
2020
Q2 		$343K Buy
6,533
+33
+0.5% +$1.38K ﹤0.01% 780
2020
Q1 		$218K Sell
6,500
-1,962
-23% -$81.5K ﹤0.01% 838
2019
Q4 		$383K Buy
8,462
+17
+0.2% +$722 ﹤0.01% 801
2019
Q3 		$321K Sell
8,445
-40
-0.5% -$1.6K ﹤0.01% 824
2019
Q2 		$369K Hold
8,485
– – ﹤0.01% 814
2019
Q1 		$323K Buy
8,485
+98
+1% +$3.83K ﹤0.01% 805
2018
Q4 		$361K Sell
8,387
-24
-0.3% -$1.12K ﹤0.01% 742
2018
Q3 		$413K Hold
8,411
– – ﹤0.01% 818
2018
Q2 		$270K Hold
8,411
– – ﹤0.01% 908
2018
Q1 		$262K Hold
8,411
– – ﹤0.01% 914
2017
Q4 		$384K Buy
+8,411
New +$333K ﹤0.01% 821

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

KeyBank National Association's PCRX Position: Q3 2023 in Review

KeyBank National Association sold out of Pacira BioSciences (PCRX) in Q3 2023, closing a stake of 9,683 shares — an estimated $388K sold.

KeyBank National Association first reported a position in PCRX in Q4 2017 and held it in 23 quarters. The position peaked at $502K in Q1 2022. 261 funds tracked by Wall St. Rank hold PCRX as of Q3 2023.

  • KeyBank National Association reported no remaining Pacira BioSciences position as of Q3 2023 after selling out during the quarter.
  • KeyBank National Association sold 9,683 Pacira BioSciences shares in Q3 2023, an estimated $388K.
  • KeyBank National Association first reported a position in Pacira BioSciences in Q4 2017 and held it in 23 quarters.
  • KeyBank National Association's Pacira BioSciences position peaked at $502K in Q1 2022.
  • 261 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2023.

Based on KeyBank National Association's 13F filing for Q3 2023, filed 8 Nov 2023.